View our list of available Coronavirus (COVID-19, SARS-CoV-2, 2019-nCOV) antibodies, recombinant proteins, ELISA Kits... Options Full Datasheet Printer Friendly Datasheet Prepare for Printing Full Datasheet Printer Friendly Datasheet Prepare for Printing Have Questions? Ask Us! Request A Quote Today! Add To Compare List TAK-875, inhibitor Catalog # MBS8506575 Unit / Price 5 mg / $910 +1 FREE 8GB USB 5x5 mg / $3,910 +4 FREE 8GB USB Product Name Product Info Accession #s Product Desc Diseases/Tissues/Pathways Applications References Product Name TAK-875, Inhibitor Popular Item Full Product Name TAK-875 Product Gene Name TAK-875, inhibitor[Similar Products] Research Use Only For Research Use Only. Not for use in diagnostic procedures. TOP Solubility DMSO >=105 mg/mL - Water <1 mg/mL - Ethanol >=11 mg/mL Formula C29H32O7S.1/2H2O CAS Number 1000413-72-8 Preparation and Storage Stable for; 2 years at -20 degree C Powder1 week -4 degree C in DMSO1 month -80 degree C in DMSO ISO Certification Manufactured in an ISO 9001:2015 Certified Laboratory. Other Notes Small volumes of TAK-875, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply. TOP Related Product Information for TAK-875, inhibitor TAK-875 is a potent, selective and orally bioavailable GPR40 agonist with an EC50 of 0.072 muM. TAK-875 is a new agent applied in the treatment of type 2 diabetes. TAK-875 not only elevated the levels of intra-cellular inositol monophosphate as well as calcium contents in rat insulinoma INS-1 833/15 cells but also improved the tolerance of glucose and amplified insulin secretion when orally administered in tolerance test. However, TAK-875 didn't increase the secretion of insulin and cause hypoglycemia when 30 mg/kg dosage of TAK-875 was given in fasted normal Sprague Dawley rats. Conversely, TAK-875 with a dosage of 10 mg/kg (p.o.) not only significantly improved plasma insulin levels but also decreased fasting hyperglycemia in male Zucker diabetic fatty rats. [1][2] Product Categories/Family for TAK-875, inhibitor Stem Cells; Cancer; Cardiovascular; Cell Biology; Epigenetics & Nuclear Signaling; Developmental Biologys; Immunology; Drug Discovery Products; Metabolism; Neuroscience; Signal Transduction Testing Data of TAK-875, inhibitor TOP Molecular Weight 533.63 TOP Precautions All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines. Disclaimer While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information. TOP